プロモーションスケジュール ProMIS Neurosciences, Inc.
詳細なスケジュール
簡易グラフ
会社について ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. さらに詳しく| IPO date | 2007-07-17 |
|---|---|
| ISIN | CA74346M4065 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.promisneurosciences.com |
| Цена ао | 0.77 |
| 1日あたりの価格変動: | 0% (0.735) |
|---|---|
| 週ごとの価格変動: | -10.37% (0.82) |
| 月ごとの料金変更: | -17.42% (0.89) |
| 3ヶ月間の価格変動: | -21.81% (0.94) |
| 半年間の価格変動: | -43.89% (1.31) |
| 年間の価格変動: | -64.83% (2.09) |
| 3年間の価格推移: | +635% (0.1) |
| 5年間の価格推移: | +332.35% (0.17) |
| 10年間の価格推移: | 0% (0.735) |
| 年初からの価格変動: | -18.33% (0.9) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Sphera Funds Management Ltd. | 1834042 | 9.67 |
| Ally Bridge Group (NY) LLC | 1066674 | 5.63 |
| Affinity Asset Advisors, LLC | 265958 | 1.4 |
| Northeast Financial Consultants Inc | 100000 | 0.53 |
| IEQ CAPITAL, LLC | 30799 | 0.16 |
| Fiduciary Trust Company (MA) | 20008 | 0.11 |
| Kingsview Wealth Management, LLC | 11100 | 0.06 |
| Claret Asset Management Corp | 10830 | 0.06 |
| UBS Group AG | 5926 | 0.03 |
| Bank of America Corporation | 1666 | 0.01 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Dr. Neil R. Cashman M.D. | Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director | 333.8k | 1952 (73 年) |
| Mr. Gavin T. Malenfant | Chief Operating Officer | 413.49k | 1964 (61 年) |
| Mr. Daniel E. Geffken M.B.A. | Chief Financial Officer | 89.99k | 1957 (68 年) |
| Dr. Johanne Kaplan Ph.D. | Chief Development Officer | 263.07k | 1960 (65 年) |
| Dr. Ernest D. Bush Ph.D. | Head of Pharmacology/Toxicology & Senior Consultant | N/A | |
| Dr. David Wishart Ph.D. | Chief Physics Officer | N/A | |
| Mr. Dennis Chen Ph.D. | Head of Manufacturing & Senior Consultant | N/A | |
| Dr. Larry Douglas Altstiel M.D., Ph.D. | Chief Medical Officer | N/A | 1950 (75 年) |
| Mr. Neil K. Warma M.B.A. | President, Interim CEO & Director | 40k | 1963 (62 年) |
| Mr. Eugene W. Williams | Co-Founder & Chairman | 1959 (66 年) |
住所: Canada, Toronto. ON MS E, 1920 Yonge Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.promisneurosciences.com
Webサイト: https://www.promisneurosciences.com
